agm announcement, page-38

The price per course of USD1,125 for Ropren® in Russia that was signalled in the Chairman’s letter in the 2008 Annual Report has been confirmed. Written agreements with nine hospitals in St Petersburg for supply at that price are currently being finalised. A number of important initiatives in relation to Ropren® distribution throughout the remainder of Russia are close to finalisation and details will be revealed when documentation is complete.


It's quite simple really you either believe what they have told us or you don't.
I really can't see how we can get to this point with everything that's happened and everything that's going to happen (new factory) for Ropren to fail due to lack of interest or price to high etc.